Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500098426Phase 4Not yet recruiting
Phase 4, randomised trial in Mycoplasmal pneumonia comparing Control group: azithromycin with Trial group: doxycycline (2 arms). Primary endpoint: Hospitalization within 7 days after start of treatment. Planned start Mar 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500098426.